Literature DB >> 8052821

Antibiotic susceptibility of Mycobacterium marinum.

A Forsgren1.   

Abstract

A radiometric respirometric technique (Bactec) which is highly standardized for Mycobacterium tuberculosis was used for antibiotic susceptibility testing of clinical isolates of M. marinum. Ciprofloxacin, clarithromycin, rifampicin and trimethoprim/sulfamethoxazole were effective at clinically relevant concentrations. Doxycycline, erythromycin and roxithromycin were ineffective. These in vitro results are discussed in relation to documented clinical experience.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8052821     DOI: 10.3109/00365549309008579

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

1.  Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection.

Authors:  M R Weinstein; D E Low; T Mazzulli
Journal:  Can J Infect Dis       Date:  1997-05

2.  Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.

Authors:  C M Flynn; C M Kelley; M S Barrett; R N Jones
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

3.  Antibiotic susceptibility pattern of Mycobacterium marinum.

Authors:  A Aubry; V Jarlier; S Escolano; C Truffot-Pernot; E Cambau
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

4.  Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones.

Authors:  Martin Bråbäck; Kristian Riesbeck; Arne Forsgren
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 5.  Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.